Step 1: Understanding the Concept:
Glycolysis is the metabolic pathway that converts glucose into pyruvate.
Specific chemical inhibitors can target key enzymes in this pathway, blocking glycolysis and causing preceding metabolic intermediates to accumulate.
Step 2: Detailed Explanation:
Let us evaluate both the Assertion and the Reason:
- Reason (R): Enolase is the ninth enzyme of glycolysis, catalyzing the dehydration of 2-phosphoglycerate (2-PG) to phosphoenolpyruvate (PEP).
This enzyme requires magnesium ions ($\text{Mg}^{2+}$) as cofactors to coordinate with the substrate at the active site.
In the presence of inorganic phosphate ($\text{P}_i$), fluoride ions ($\text{F}^-$) bind with $\text{Mg}^{2+}$ and phosphate to form a highly stable magnesium fluorophosphate complex at the active site, competitively and strongly inhibiting enolase.
Thus, Reason (R) is true.
- Assertion (A): Inhibiting enolase prevents the conversion of 2-phosphoglycerate (2-PG) to phosphoenolpyruvate (PEP).
As a result, 2-PG accumulates in the cell.
Because the preceding step in glycolysis—catalyzed by phosphoglycerate mutase—is freely reversible, 2-phosphoglycerate is in rapid equilibrium with 3-phosphoglycerate (3-PG):
\[ \text{3-phosphoglycerate} \rightleftharpoons \text{2-phosphoglycerate} \]
As 2-PG accumulates, the equilibrium shifts, causing a corresponding buildup of 3-phosphoglycerate.
Therefore, adding fluoride causes both 2-PG and 3-PG to accumulate in fermenting extracts.
Thus, Assertion (A) is true, and the mechanism described in Reason (R) directly explains this accumulation.
Step 3: Final Answer:
Both (A) and (R) are true, and (R) is the correct explanation of (A), corresponding to option (A).